BackgroundCheck.run
Search For

Steven X Zhang, 69701 W Imperial Hwy UNIT 712, La Habra, CA 90631

Steven Zhang Phones & Addresses

472 W Duarte Rd UNIT C, Arcadia, CA 91007   

928 Fairview Ave, Arcadia, CA 91007    626-4461588   

La Habra, CA   

165 E Commercial St, San Dimas, CA 91773   

Riverside, CA   

Diamond Bar, CA   

San Gabriel, CA   

Darien, IL   

Stafford, VA   

Rosemead, CA   

Languages

English

Mentions for Steven X Zhang

Career records & work history

Medicine Doctors

Steven Zhang Photo 1

Steven Y Zhang, Whittier CA - LAC

Specialties:
Acupuncture
Address:
12470 Washington Blvd, Whittier, CA 90602
562-6934800 (Phone)
Languages:
English

Publications & IP owners

Us Patents

Stabilized Oxymetazoline Formulations And Their Uses

US Patent:
2019036, Dec 5, 2019
Filed:
Apr 10, 2019
Appl. No.:
16/380538
Inventors:
- Wayne PA, US
Kevin WARNER - Anaheim CA, US
Steven ZHANG - Newton MA, US
Gurpreet AHLUWALIA - Tustin CA, US
Amy KUANG - Irvine CA, US
International Classification:
A61K 31/4164
A61K 9/00
A61K 47/14
A61K 9/06
A61K 9/107
A61K 31/4174
A61K 47/10
A61K 47/12
A61K 47/18
A61K 47/44
Abstract:
The present invention provides stabilized cream formulations of oxymetazoline and uses thereof. The present invention also provides a method of treating facial erythema associated with rosacea in a patient in need of such treatment, comprising topically administering once or twice daily to the site of erythema on the face of the patient a pharmaceutical composition comprising 0.5%, 1.0% or 1.5% oxymetazoline or a pharmaceutically acceptable salt thereof as the sole active ingredient.

Stabilized Oxymetazoline Formulations And Their Uses

US Patent:
2018026, Sep 20, 2018
Filed:
May 21, 2018
Appl. No.:
15/984918
Inventors:
- Irvine CA, US
Kevin Warner - Anaheim CA, US
Steven Zhang - Newton MA, US
Gurpreet Ahluwalia - Tustin CA, US
Amy Kuang - Irvine CA, US
International Classification:
A61K 31/4164
A61K 9/107
A61K 9/06
A61K 47/14
A61K 9/00
A61K 47/12
A61K 47/18
A61K 47/10
A61K 31/4174
A61K 47/44
Abstract:
The present invention provides stabilized cream formulations of oxymetazoline and uses thereof. The present invention also provides a method of treating facial erythema associated with rosacea in a patient in need of such treatment, comprising topically administering once or twice daily to the site of erythema on the face of the patient a pharmaceutical composition comprising 0.5%, 1.0% or 1.5% oxymetazoline or a pharmaceutically acceptable salt thereof as the sole active ingredient.

Stabilized Oxymetazoline Formulations And Their Uses

US Patent:
2017015, Jun 1, 2017
Filed:
Feb 10, 2017
Appl. No.:
15/429873
Inventors:
- Irvine CA, US
Kevin Warner - Anaheim CA, US
Steven Zhang - Newton MA, US
Gurpreet Ahluwalia - Tustin CA, US
Amy Kuang - Irvine CA, US
International Classification:
A61K 31/4174
A61K 9/06
A61K 9/107
A61K 47/44
A61K 47/10
A61K 47/12
A61K 47/18
A61K 9/00
A61K 47/14
Abstract:
The present invention provides stabilized cream formulations of oxymetazoline and uses thereof. The present invention also provides a method of treating facial erythema associated with rosacea in a patient in need of such treatment, comprising topically administering once or twice daily to the site of erythema on the face of the patient a pharmaceutical composition comprising 0.5%, 1.0% or 1.5% oxymetazoline or a pharmaceutically acceptable salt thereof as the sole active ingredient.

Stabilized Oxymetazoline Formulations And Their Uses

US Patent:
2015035, Dec 17, 2015
Filed:
Jun 11, 2015
Appl. No.:
14/737360
Inventors:
- Irvine CA, US
Kevin Warner - Anaheim CA, US
Steven Zhang - Newton MA, US
Gurpreet Ahluwalia - Tustin CA, US
Amy Kuang - Irvine CA, US
International Classification:
A61K 31/4164
Abstract:
The present invention provides stabilized cream formulations of oxymetazoline and uses thereof. The present invention also provides a method of treating facial erythema associated with rosacea in a patient in need of such treatment, comprising topically administering once or twice daily to the site of erythema on the face of the patient a pharmaceutical composition comprising 0.5%, 1.0% or 1.5% oxymetazoline or a pharmaceutically acceptable salt thereof as the sole active ingredient.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.